menu search

Uk joins eu in approving xbb.1.5 jab from pfizer-biontech, but others subvariants are emerging

An updated Covid-19 vaccine made by Pfizer Inc (NYSE:PFE) and BioNTech has been approved by the UK medical regulator, amid a rise in new variants and ...

September 6, 2023, 9:47 am

Nuvectis: early stage company that's low on cash

Nuvectis is developing precision medicines for cancer patients, with lead asset NXP800 targeting ARID1a-mutated ovarian cancer. Preclinical trials hav...

September 6, 2023, 8:03 am

60 degrees pharmaceuticals to participate in h.c. wainwright 25th annual global investment conference

WASHINGTON, Sept. 06, 2023 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals Inc. (“60P” or the “Company”) (Nasdaq: SXTP ), a pharmaceutical comp...

September 6, 2023, 7:31 am

Carmell corporation announces completion of post-merger integration with axolotl biologix and new organizational structure aligned with focus on aesthetics

PITTSBURGH, Sept. 05, 2023 (GLOBE NEWSWIRE) — Carmell Corporation (Nasdaq: CTCX) (“Carmell”), a regenerative care company, today announced the c...

September 5, 2023, 10:03 pm

Solid biosciences to participate at upcoming investor conferences

CHARLESTOWN, Mass., Sept. 05, 2023 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing genetic medicines fo...

September 5, 2023, 12:56 pm

Could this biosimilar drug be novartis' next blockbuster?

Novartis' biosimilar candidate to Eylea has proven just as safe and effective. The medicine could gener...

September 5, 2023, 10:15 am

Zenas biopharma announces strategic license and collaboration agreement with bristol myers squibb to develop and commercialize novel bi-functional antibody obexelimab in japan, south korea, taiwan, si

Collaboration furthers Zenas’ vision to bring innovative immunology-based medicines to patients around the world by leveraging Bristol Myers Squibb�...

September 5, 2023, 10:00 am

Zenas biopharma announces strategic license and collaboration agreement with bristol myers squibb to develop and commercialize novel bi-functional antibody obexelimab in japan, south korea, taiwan, si

Collaboration furthers Zenas’ vision to bring innovative immunology-based medicines to patients around the world by leveraging Bristol Myers Squibb�...

September 5, 2023, 10:00 am

Transdermal skin patches market is anticipated to attain us$ 11.5 billion at a cagr of 4.6% by 2031: transparency market research, inc.

Increasing technological advances in transdermal patches and increases in the advantages of transdermal medicines over oral and ingested medications a...

September 4, 2023, 10:07 am

Novartis sues us government over medicare drug price regulation

Swiss drugmaker Novartis on Friday said it had sued the U.S. government in an attempt to halt the Medicare drug-price negotiation program, which inclu...

September 1, 2023, 4:20 pm

Ultracapacitors market size to worth us$ 11.22 billion by 2031: transparency market research inc.

Increased use of ultracapacitors is projected to increase the marriage of pulse power design and particular energy storage in a number of industries, ...

September 1, 2023, 10:49 am

Generic drugmakers start shipping copies of takeda's adhd drug vyvanse

Drugmakers have begun shipping copycat versions of Takeda Pharmaceutical's drug Vyvanse, which is expected to offset the ongoing shortage of the ADHD ...

August 31, 2023, 3:49 pm

Beam therapeutics to participate in upcoming september investor conferences

CAMBRIDGE, Mass., Aug. 31, 2023 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medic...

August 31, 2023, 10:30 am

Third harmonic bio to participate in the morgan stanley global healthcare conference

SAN FRANCISCO, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a biopharmaceutical company focused on advancing the next wa...

August 31, 2023, 8:30 am

Disc medicine to participate in upcoming investor conferences

WATERTOWN, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the disc...

August 30, 2023, 8:15 pm

Disc medicine to participate in upcoming investor conferences

WATERTOWN, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the disco...

August 30, 2023, 4:15 pm

Pfizer, biontech updated covid vaccine to treat new variants gets chmp recommendation use in europe

Pfizer Inc. PFE, -0.25% and BioNTech SE BNTX, +0.58% said Wednesday that its updated COVID-19 vaccine, which is tailored to the new Omicron XBB.1.5 va...

August 30, 2023, 10:15 am

Poolbeg pharma highlights climate change impact on infectious diseases

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) has highlighted how climate change, marked by increasing global temperatures, is intensifying the effects ...

August 30, 2023, 8:21 am

Clene to present at upcoming september conferences

SALT LAKE CITY, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary...

August 30, 2023, 8:20 am

Eu regulator backs authorizing pfizer's vaccine for coronavirus variant xbb.1.5

The European Medicines Agency (EMA) on Wednesday said its human medicines committee (CHMP) recommended authorizing an adapted Comirnaty COVID-19 vacci...

August 30, 2023, 8:18 am


Search within

Pages Search Results: